Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for ImmunoTech (AIM) over the last 11 years, with Q3 2025 value amounting to $362000.0.

  • ImmunoTech's Other Non-Current Assets fell 8667.16% to $362000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $362000.0, marking a year-over-year decrease of 8667.16%. This contributed to the annual value of $1.1 million for FY2024, which is 3412.32% down from last year.
  • Latest data reveals that ImmunoTech reported Other Non-Current Assets of $362000.0 as of Q3 2025, which was down 8667.16% from $351000.0 recorded in Q2 2025.
  • ImmunoTech's 5-year Other Non-Current Assets high stood at $2.7 million for Q3 2024, and its period low was $351000.0 during Q2 2025.
  • Its 3-year average for Other Non-Current Assets is $1.5 million, with a median of $1.7 million in 2023.
  • In the last 5 years, ImmunoTech's Other Non-Current Assets surged by 2921.03% in 2024 and then tumbled by 8667.16% in 2025.
  • ImmunoTech's Other Non-Current Assets (Quarter) stood at $1.7 million in 2023, then plummeted by 34.12% to $1.1 million in 2024, then crashed by 67.45% to $362000.0 in 2025.
  • Its Other Non-Current Assets was $362000.0 in Q3 2025, compared to $351000.0 in Q2 2025 and $745000.0 in Q1 2025.